Enlitic Stock

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

Sign up today and learn more about Enlitic Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Enlitic Stock

Enlitic Inc. is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis. With a platform developed by renowned data scientists, machine learning practitioners, and medical experts, Enlitic is able to analyze a wide variety of healthcare data sources, including billions of clinical cases, to improve diagnostic accuracy, speed and patient outcomes, as well as accelerate pharmaceutical research and drug trials. Named one of the world’s “50 Smartest Companies” by MIT Tech Review, Enlitic is based San Francisco and serves customers around the world.

Funding History

October 2014$5.0M
October 2015$10.0M
April 2019$15.0M


Chief Executive Officer

Kevin Lyman

Head of Product, Marketing & Strategy

Vanessa Sawyer


cybertrend - Jan, 13 2016

Tech Startup News

businessspectator - Nov, 4 2015

Machine learning to help patients

techrepublic - Jun, 29 2015

5 AI startups to watch in 2015

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: